Japan's Sawai Pharma to buy US generics maker

OSAKA — Sawai Pharmaceutical will buy the generics business of U.S. drugmaker Upsher-Smith Laboratories for $1.05 billion, the Japanese company said Thursday, eager to make up for lost time after its first push into the American market stalled.
( read original story …)


Related Post

Feature: Game Bar Space Station – Osaka̵...
views 61
I think there are more video game bars in Osaka ci...
Exclusive: ANZ's sale of insurance unit attra...
views 171
which has been valued at $3.33 billion by the bank...
Tokyo stocks rise from bell on hopes for successfu...
views 212
TOKYO, Feb. 13 (Xinhua) -- Tokyo stocks rose from ...
Tokyo Olympics could feature mixed shooting events...
views 292
Men and women could be competing against each othe...
Japan urged to tap young workforce ahead of 2030: ...
views 228
The task force involves academics and members of t...
Japan reaches out
views 219
With ample liquidity supplied by its central bank ...
As Nikkei Hits Highest Since 1992, Some Say Party ...
views 138
It’s pick-a-number time for Japanese stock bulls a...
Japan’s love of shogi reignited thanks to 14...
views 172
according to Kyodo news. He started attending shog...
Japan’s Mitsui Fudosan to develop $3.6 billi...
views 196
TOKYO (Reuters) - Japanese property developer Mits...
Japanese Bank Falls Most Since 1975 Over Faked Doc...
views 85
Suruga Bank Ltd., the worst-performing bank stock ...